Výsledky vyhledávání

  1. 1.
    0585443 - ÚI 2025 GB eng A - Abstrakt
    Morrone, D. - Chao, T. F. - Chen, C. - Choi, E. - De Groot, J. - Kirchhof, P. - Pecen, Ladislav - Tse, H. - Unverdorben, M. - De Caterina, R.
    Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry.
    European Heart Journal. Roč. 44, Suppl. 2 (2023). ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0353152
     
     
  2. 2.
    0585442 - ÚI 2025 GB eng A - Abstrakt
    Fumagalli, S. - Diemberger, I. - Bakhai, A. - Pecen, Ladislav - Lamparter, M. - Kirchhof, P. - De Caterina, R.
    Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up.
    European Heart Journal. Roč. 44, Suppl. 2 (2023). ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0353151
     
     
  3. 3.
    0572208 - ÚI 2024 GB A - Abstrakt
    De Caterina, R. - Unverdorben, M. - Lee, B.-C. - Yamashita, T. - Lin, W. S. - Wang, C. C. - Pecen, Ladislav - Borrow, A. - Chen, C. - Kirchhof, P.
    Real-world effectiveness and safety of edoxaban in patients with and without a history of ischaemic stroke: results from the ETNA-AF programme.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 2702-2702. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342977
     
     
  4. 4.
    0572207 - ÚI 2024 GB A - Abstrakt
    Siller-Matula, J. M. - Unverdorben, M. - Wang, C. C. - Koretsune, Y. - Pecen, Ladislav - Borrow, A. - Chen, C. - Kirchhof, P. - De Caterina, R.
    The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 2700-2700. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342976
     
     
  5. 5.
    0572206 - ÚI 2024 GB A - Abstrakt
    Russo, V. - Wang, C. C. - Unverdorben, M. - Yamashita, T. - Pecen, Ladislav - Borrow, A. - Chen, C. - Kirchhof, P. - De Caterina, R.
    Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 2701-2701. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342975
     
     
  6. 6.
    0572205 - ÚI 2024 GB A - Abstrakt
    De Vries, T. A. C. - Pecen, Ladislav - Komen, J. J. - Diemberger, I. - Fumagalli, S. - De Groot J. R. - Kirchhof, P. - De Caterina, R.
    Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 2544-2544. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342974
     
     
  7. 7.
    0572204 - ÚI 2024 GB A - Abstrakt
    Ameri, P. - Schnabel, R. B. - Pecen, Ladislav - Diemberger, I. - Gwechenberger, M. - Siller-Matula, J. M. - Kirchhof, P. - De Caterina, R.
    Two-year outcomes of patients with atrial fibrillation and heart failure: the ETNA-AF-Europe registry.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 619-619. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342973
     
     
  8. 8.
    0572203 - ÚI 2024 GB A - Abstrakt
    De Vries, T. A. C. - Pecen, Ladislav - Komen, J. J. - De Groot J. R. - Kirchhof, P. - De Caterina, R.
    The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 618-618. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342972
     
     
  9. 9.
    0572202 - ÚI 2024 GB A - Abstrakt
    Patti, G. - Pecen, Ladislav - Casalnuovo, G. - Kirchhof, P. - De Caterina, R.
    Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry.
    European Heart Journal. Roč. 43, Suppl. 2 (2022), s. 2405-2405. ISSN 0195-668X. E-ISSN 1522-9645
    Institucionální podpora: RVO:67985807
    Trvalý link: https://hdl.handle.net/11104/0342971
     
     
  10. 10.
    0557826 - ÚI 2023 GB eng A - Abstrakt
    Gampenrieder, S. - Dezentje, V. - Lambertini, M. - de Nonneville, A. - Marhold, M. - Le Du, F. - Serrano, C. - Costa, D. - Blondeaux, E. - Del Mastro, L. - Bertucci, F. - Goncalves, A. - Bartsch, R. - Deleuze, A. - Salgado, A. - Vitorino, M. - Tinchon, C. - Pecen, Ladislav - Rinnerthaler, G. - Greil, R.
    Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT).
    Annals of Oncology. Roč. 33, Suppl. 3 (2022), S208-S208. ISSN 0923-7534. E-ISSN 1569-8041
    Trvalý link: http://hdl.handle.net/11104/0332064
     
     

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.